CERo Therapeutics Holdings, Inc. (CERO)

NASDAQ: CERO · IEX Real-Time Price · USD

0.200

-0.043 (-17.66%)

At close: Jul 19, 2024, 4:00 PM

0.194

-0.006 (-3.00%)

Pre-market: Jul 22, 2024, 9:17 AM EDT

CERO Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-	-7.29	-11.83	-10.63
Depreciation & Amortization	-	1.12	1.07	0.74
Share-Based Compensation	-	0.1	0.38	0.29
Other Operating Activities	-	0.29	-1.33	-0.49
Operating Cash Flow	-	-5.79	-11.71	-10.09
Capital Expenditures	-	0	-0.69	-0.61
Investing Cash Flow	-	0	-0.69	-0.61
Share Issuance / Repurchase	-	0.01	0.01	0.06
Debt Issued / Paid	-	0.61	0	0
Other Financing Activities	-	-0.04	-	-
Financing Cash Flow	-	0.57	0.01	0.06
Net Cash Flow	-	-5.22	-12.4	-10.65
Free Cash Flow	-	-5.79	-12.4	-10.71
Free Cash Flow Per Share	-	-0.64	-1.38	-1.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).